V. Komrska

550 total citations
14 papers, 403 citations indexed

About

V. Komrska is a scholar working on Hematology, Genetics and Infectious Diseases. According to data from OpenAlex, V. Komrska has authored 14 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Genetics and 2 papers in Infectious Diseases. Recurrent topics in V. Komrska's work include Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). V. Komrska is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). V. Komrska collaborates with scholars based in Czechia, Poland and Russia. V. Komrska's co-authors include Aleš Homola, Radek Pádr, Radim Mazanec, Jan Štulík, Petr Kobylka, Eva Syková, J Neuwirth, Martin Bojar, David Habart and Ilona Hromadníková and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

V. Komrska

14 papers receiving 386 citations

Peers

Countries citing papers authored by V. Komrska

Since Specialization

Citations

This map shows the geographic impact of V. Komrska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Komrska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Komrska more than expected).

Fields of papers citing papers by V. Komrska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Komrska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Komrska. The network helps show where V. Komrska may publish in the future.

Co-authorship network of co-authors of V. Komrska

This figure shows the co-authorship network connecting the top 25 collaborators of V. Komrska. A scholar is included among the top collaborators of V. Komrska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Komrska. V. Komrska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects 2021 ·Thrombosis and Haemostasis ·Victor S. Blanchette, (unknown), Viviane Grassmann, Chris Barnes, Manuel Carção, Julie Curtin, Shannon Jackson, (unknown), V. Komrska, David Lillicrap, Massimo Morfini, (unknown), Derek Stephens, Ester Zápotocká, Margaret L. Rand, Jan Blatný	5
2	octanate^®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment 2020 ·Therapeutic Advances in Hematology ·Anna Klukowska, V. Komrska, (unknown), (unknown), Toshko Lissitchkov, Johannes Oldenburg, Carmen Escuriola Ettingshausen	3
3	A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a 2018 ·Blood ·Victor S. Blanchette, (unknown), David Lillicrap, Shannon Jackson, Massimo Morfini, (unknown), Manuel Carção, Margaret L. Rand, Derek Stephens, (unknown), Ester Zápotocká, V. Komrska, Jan Blatný	1
4	Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate^®: Final report from a prospective study 2018 ·Haemophilia ·Anna Klukowska, V. Komrska, (unknown), A. Pavlova, (unknown), (unknown), Larisa Belyanskaya, Olaf Walter, Paweł Łaguna	7
5	Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 2003 2015 ·Blood Coagulation & Fibrinolysis ·Jan Blatný, V. Komrska, (unknown), Miroslav Penka, Petra Ovesná	5
6	The PUP-GCP Clinical Trial: A Low Inhibitor Rate in Previously Untreated Patients with Severe Hemophilia a Treated with Octanate 2014 ·Blood ·Sigurd Knaub, Anna Klukowska, V. Komrska, Paweł Łaguna, (unknown), Martina Jansen	1
7	Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius 2011 ·Haemophilia ·Ondřej Souček, V. Komrska, Zdeněk Hlávka, Ondřej Cinek, Miloslav Roček, D. Zemková, Jan Lebl, (unknown)	19
8	Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study 2010 ·Haemophilia ·Anna Klukowska, V. Komrska, (unknown), Paweł Łaguna	13
9	Pharmacokinetics, Efficacy and Safety of IMMUNATE® Solvent/Detergent (IMMUNATE® S/D) in Previously Treated Patients with Severe Hemophilia A: Results of a Prospective, Multicenter, Open-Label Phase III Study 2008 ·Acta Haematologica ·László Nemes, Toshko Lissitchkov, (unknown), Anna Klukowska, V. Komrska, R. Zimmermann, G. Auerswald, Werner Engl, (unknown), Borislava G. Pavlova, Hartmut J. Ehrlich	3
10	Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera 2008 ·British Journal of Haematology ·Holger Cario, Klaus Schwarz, Jan M. Herter, V. Komrska, Mary Frances McMullin, Milen Minkov, Charlotte M. Niemeyer, Dagmar Pospı́šilová, Harald Reinhard, Klaus‐Michael Debatin, Heike L. Pahl	20
11	Evaluation of pharmacokinetics, efficacy and safety of Immunate^® solvent detergent in previously treated patients with severe haemophilia A 2006 ·Haemophilia ·László Nemes, Toshko Lissitchkov, Anna Klukowska, (unknown), V. Komrska, R. Zimmermann, G. Auerswald, Werner Engl, Borislava G. Pavlova, (unknown), H. J. Ehrlich	10
12	Autologous Bone Marrow Transplantation in Patients with Subacute and Chronic Spinal Cord Injury 2006 ·Cell Transplantation ·Eva Syková, Aleš Homola, Radim Mazanec, (unknown), (unknown), Petr Kobylka, Radek Pádr, J Neuwirth, V. Komrska, (unknown), Jan Štulík, Martin Bojar	248
13	Replicate real‐time PCR testing of DNA in maternal plasma increases the sensitivity of non‐invasive fetal sex determination 2003 ·Prenatal Diagnosis ·Ilona Hromadníková, (unknown), (unknown), (unknown), J. Köfer, V. Komrska, David Habart	58
14	Infection-Associated Hemophagocytic Syndrome Complicated by Infectious Lymphoproliferation: A Case Report 1996 ·Pediatric Hematology and Oncology ·(unknown), Jan Starý, Petr Sedláček, Petr Smíšek, J Vavřinec, V. Komrska, K Roubalová, (unknown), (unknown), (unknown), Moustapha Hassan	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact